EXCELLOS
LIVE

Serial Number

97805943

Owner

Excellos, Incorporated

Attorney

Richard P. Sybert

First Use Date

Jan 25, 2022

Filing Date

Feb 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EXCELLOS Trademark

Serial Number: 97805943 • Registration: 7431789

EXCELLOS is a trademark filed by Excellos, Incorporated on February 22, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Excellos, Incorporated

3636 Gateway Center Ave., Ste 100B
San Diego, CA 92102

Entity Type: 03

Trademark Details

Filing Date

February 22, 2023

Registration Date

July 2, 2024

First Use Anywhere

January 25, 2022

First Use in Commerce

January 25, 2022

Published for Opposition

April 16, 2024

Goods & Services

bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies

distributing human blood products for others, namely, transportation of blood products for others; Storage and retrieval of blood, peripheral blood mononuclear cells (PBMCs), tissue and stem cells for scientific, laboratory, and medical research

Pharmaceutical preparations for immunotherapy, namely, mononuclear cells, progenitor cells, and antibody preparations for medical purposes

Cells and biological tissue, namely, blood, lymphocytes, T cells, stem cells, and T cell receptors for use in scientific, laboratory, and medical research; Cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation; lymphocytes in the nature of cells for scientific and research use; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for clinical trial, scientific, laboratory, and medical research; Biological reagents for scientific and medical research use; Biological preparations, namely, mononuclear cells, progenitor cells, and antibody preparations for use in medical clinical trials and medical research in the field of immunotherapy

Medical services, namely, processing of stem cells and white blood cells for use by others; stem cell and white blood cell storage, namely, stem cell and white blood cell bank services; collection and preservation of human blood, blood components, apheresis, peripheral blood mononuclear cells (PBMCs), plasma and bone marrow

Medical research, namely research in the field of the blood process of patients' blood to isolate lymphocytes for the use in immunotherapy for therapeutic medical research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 8, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 7, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 23, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2023 NWOS
NEW APPLICATION ENTERED
Feb 25, 2023 NWAP